TOLULOPE GREEN-YESU: Open Payments
NPI 1164976411 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 8 companies in 2025. Trend: 2023 $326 · 2024 $176 · 2025 $443
Food & beverage: $388Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| Indivior Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Alkermes, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, COBENFY, SUBLOCADE, CAPLYTA, VIVITROL, Qelbree, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
